European Commission grants marketing authorization to Valneva’s COVID-19 vaccine
The logo of Franco-Austrian biotechnology company Valneva is seen outside its headquarters in Vienna, Austria, December 16, 2021. REUTERS/Lisi Niesner Join now for FREE unlimited access to Reuters.com Register June 24 (Reuters) – French drugmaker Valneva’s COVID-19 vaccine (VLS.PA) has received marketing authorization from the European Commission (EC) for useRead More →

/cloudfront-us-east-2.images.arcpublishing.com/reuters/2VLI5LXYDVNXTHXY3W3D4SSRMQ.jpg)













































:quality(70):focal(-5x-5:5x5)/cloudfront-ap-southeast-2.images.arcpublishing.com/tvnz/DLMZ32OS2REO3EEI7C3FBQPM2Y.png)






























